52 studies found for:    eye diseases AND university of iowa | Exclude Unknown
Show Display Options
Rank Status Study
21 Completed Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
Condition: Intraocular Retinoblastoma
Interventions: Drug: liposomal vincristine sulfate;   Drug: carboplatin;   Drug: etoposide
22 Active, not recruiting
Has Results
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab;   Drug: bevacizumab
23 Active, not recruiting Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Condition: Age Related Macular Degeneration
Intervention: Drug: 3 dose cohorts gene therapy
24 Recruiting Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Childhood Atypical Teratoid/Rhabdoid Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
Intervention: Other: cytology specimen collection procedure
25 Active, not recruiting Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
Conditions: Extraocular Retinoblastoma;   Intraocular Retinoblastoma;   Recurrent Retinoblastoma
Interventions: Other: questionnaire administration;   Other: laboratory biomarker analysis
26 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
27 Completed A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Fabrazyme (agalsidase beta)
28 Recruiting Inflammation Inhibition in Prediabetic Humans
Conditions: Prediabetes;   Obese
Interventions: Drug: Salsalate;   Drug: Placebo
29 Completed
Has Results
Sudden Deafness Treatment Trial
Condition: Sudden Deafness
Interventions: Drug: prednisone;   Drug: methylprednisolone sodium succinate
30 Completed Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Intervention: Drug: Pramipexole
31 Completed Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neuroblastoma;   Retinoblastoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: becatecarin
32 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
33 Active, not recruiting Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin;   Drug: midostaurin;   Other: placebo;   Drug: dexamethasone acetate
34 Active, not recruiting Efficacy of Methotrexate in Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Methotrexate;   Other: Placebo
35 Completed S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
Condition: Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
Interventions: Drug: carmustine;   Radiation: radiation therapy;   Drug: O6-Benzylguanine
36 Completed The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
Condition: Blepharitis
Interventions: Drug: Azithromycin ophthalmic solution, 1%;   Drug: Placebo
37 Active, not recruiting Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Condition: Diabetic Macular Edema
Interventions: Drug: 2.0  mg intravitreal aflibercept;   Drug: 1.25 mg intravitreal bevacizumab;   Drug: 0.3 mg intravitreal ranibizumab
38 Completed
Has Results
Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
Conditions: Vitreous Hemorrhage;   Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Saline
39 Recruiting Treatment for CI-DME in Eyes With Very Good VA Study
Condition: Diabetic Macular Edema
Interventions: Procedure: Prompt Laser;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
40 Suspended Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Conditions: Neurofibromatosis Type 1;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway Glioma
Interventions: Drug: Lenalidomide;   Other: Pharmacological Study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results    Last Page
Indicates status has not been verified in more than two years